Report finds China targeted AstraZeneca in fraud probe over cancer treatment
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, report says.